Navigation Links
Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
Date:9/10/2008

WILMINGTON, Del., Sept. 10 /PRNewswire-FirstCall/ -- Newly released results from two previously published studies demonstrated patients receiving the maintenance combination asthma therapy SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol achieved bronchodilation, or opening of the airways, within 15 minutes(1) and reported feeling their medication begin to work right away.(1) The studies evaluated onset of bronchodilation and patient perception of onset of effect(1) of SYMBICORT compared with placebo and its individual components, budesonide pressurized metered-dose inhaler (pMDI) and formoterol dry powder inhaler (DPI), in patients with asthma.(1) These data, which were published today in the Annals of Allergy, Asthma and Immunology, also showed patients were more satisfied with how quickly they felt their medication working compared with patients taking placebo.(1) SYMBICORT is a combination therapy indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older.(2) SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of asthma.(2)

"The data showed that patients receiving SYMBICORT reported they could feel their medication begin to work right away and were satisfied by how quickly their medication began to work,"(1) said lead investigator Harold Kaiser, Clinical Professor of Medicine, University of Minnesota Medical School.

Results of both studies (Study I and Study II) showed that more patients taking SYMBICORT achieved onset of clinically significant bronchodilation within 15 minutes postdose at randomization (median time, 13 minutes), compared with budesonide pMDI and placebo (P<.001).(1) Time to onset of clinically significant bronchodilation of SYMBICORT and formoterol DPI were similar.(1)

Additionally, results showed that a significantly greater percentage of patients receiving SYMBICORT versus those receiving budesonide pMDI and
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
2. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
3. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
4. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
5. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
8. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
9. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015  Bayer Corporation hosted its annual "Take Your ... Bayer HealthCare US headquarters.  This is Bayer,s second "Take Your ... Whippany campus, and Thursday,s event welcomed 230 children ... at work. Fortunately, for the kids, this was ... whose mission is "Science For A Better Life," Bayer made ...
(Date:4/24/2015)... , April 24, 2015 In today,s ... employee groups around the world to access diverse ... hours. While there are many areas to misstep ... examine which best practices are necessary and beneficial ... According to research by benchmarking firm, ...
(Date:4/24/2015)... and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) has announced ... report to their offering. The analysts ... CAGR of 7.07% over the period 2014-2019 ... segments: Equipment and Consumables. This report covers the present ... market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... May 2, 2011 NewCardio, Inc., (OTC BB: NWCI) a ... prestigious NYC Bright Lights Conference at the Le Parker Meridien ... of its kind with an exclusive focus on publicly traded ... will present on May 10, 2011 at 9 a.m. ET. ...
... Fla., May 2, 2011 The Unilens Vision Inc. ... of Directors today declared a quarterly cash dividend of $0.045 per ... record at the close of business on May 13, 2011. ... Specialty Contact Lens Company" Established in 1989, Unilens ...
Cached Medicine Technology:NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capital's Bright Lights Conference in New York City on May 10, 2011 2NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capital's Bright Lights Conference in New York City on May 10, 2011 3NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capital's Bright Lights Conference in New York City on May 10, 2011 4Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share 2
(Date:4/27/2015)... April 27, 2015 Healthpointe clinics throughout ... for nail fungi and infections. Onychomycosis, which is commonly ... to 10% of adults in the Western population. This ... in thickness. , Healthpointe’s Anaheim clinic is ... branch dedicated to providing quality skincare products and restorative ...
(Date:4/27/2015)... 2015 Puroast Coffee has signed on to ... The BattleFrog OCR is a series of rigorous courses ... participants in the training that Seals undergo, as well as ... be able to sponsor the BattleFrog events this year,” says ... we find well-suited to give people throughout the country the ...
(Date:4/27/2015)... 27, 2015 The report ... provides comparative analysis on the therapeutic development ... R&D pipelines by identifying new targets and ... Complete report on H1 2015 pipeline review ... tables and 14 figures, spread across 85 ...
(Date:4/27/2015)... Streamwood, IL (PRWEB) April 27, 2015 ... the launch of its brand new website design at ... interactive list of the company’s product catalog, both featured ... n Natural blog ( http://www.purennatural.com/blog/ ). , Pure n ... easy and satisfying shopping experience. The website is neatly ...
(Date:4/27/2015)... Covenant Care, a leading post acute care ... “Enhanced Dining” service with two primary focuses: an ... residents, patients and families to ensure that their preferences ... dining rooms so that they are more homelike, attractive ... our residents is our number one priority and we ...
Breaking Medicine News(10 mins):Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Puroast Coffee on Tour with BattleFrog 2Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Pure n Natural Systems, Inc. Launches New Website Design 2Health News:Pure n Natural Systems, Inc. Launches New Website Design 3Health News:Covenant Care Rolls Out "Enhanced Dining" Offering Restaurant Style Experience To Residents, Patients & Families 2
... Calif., Aug. 27 DURECT Corporation,(Nasdaq: DRRX ... PTIE ), its,licensee, has submitted an Investigational New ... Administration (FDA) for an abuse-resistant opioid,pain drug candidate ... third ORADUR-based opioid drug candidate covered by DURECT,s,collaboration ...
... held on September 8, 2008, BURBANK, Calif., Aug. 27 ... will be hosting a Disaster Preparedness,Event sponsored by the National ... focus of this event is to educate older adults,-- 55 ... in an emergency.,Participants will learn how to make a plan, ...
... announced yesterday at a nuclear reactor facility at Petten ... the globe to access and obtain radioactive isotopes, which ... in the United States and worldwide. The shutdown at ... similar shutdown last December of the National Research Universal ...
... WARP Services, LLC, WARP,Robotics, LLP, and Planet Earth ... Delaware and South Carolina Corporation today,announced that the company ... effective 09-02-08 through the month of September., Patrick ... WARP Robotics,LLC a subsidiary of WARP Services, LLC are ...
... NEW YORK, Aug. 27 According to the Fluoride,Action ... parties to restore,scientific integrity to the Centers for Disease ... continued unscientific support for,water fluoridation., "The simplest and ... is,for both Democrats and Republicans to put a commitment ...
... Mutual Insurance Company,(TMIC) said it would appeal to the ... Court of Appeals., The 14th Court rejected Texas ... in Harris County found TMIC acted in bad faith ... The jury also had found,that plaintiff P. Lance Morris ...
Cached Medicine News:Health News:DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology 2Health News:DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology 3Health News:SNM expresses serious concerns as isotope shortage looms 2Health News:SNM expresses serious concerns as isotope shortage looms 3Health News:Habitat for Humanity and WARP Robotics Team Up 2Health News:Habitat for Humanity and WARP Robotics Team Up 3Health News:Both Parties Need Planks to Restore Scientific Integrity at the CDC 2Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 2Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 3Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 4
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... ,Offers an average 5:1 increase in usage ... use of a standard cannula. , ,The ... offers ambulatory oxygen patients a superior alternative to ... 2-year warranty. , ...
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
Medicine Products: